Minireviews
Copyright ©The Author(s) 2022.
World J Hepatol. May 27, 2022; 14(5): 911-922
Published online May 27, 2022. doi: 10.4254/wjh.v14.i5.911
Figure 1
Figure 1 Typical contrast-enhancement pattern of a hepatocellular carcinoma in a 72-year-old woman with hepatitis C virus related cirrhosis. A: In the arterial phase (24 s after the injection of a microbubble-based contrast agent) contrast enhanced ultrasound depicts a hypervascular tumor sized 2 cm in the IV liver segment (white arrow); B: In the late phase, 199 s after the injection, the lesion shows a mild wash-out (white arrow).